Tesamorelin is a GHRH analogue specifically studied for its ability to reduce visceral adipose tissue (belly fat) in individuals with lipodystrophy and HIV-associated fat loss.

Tesamorelin is a GHRH analogue specifically studied for its ability to reduce visceral adipose tissue (belly fat) in individuals with lipodystrophy and HIV-associated fat loss.